Concepedia

Author

Ray Snyder

Institut Gustave Roussy

Also Known As

R. Snyder, R.J. Snyder, Ray Snyder, Snyder R.

5

Publications

1.7K

Citations

4

H-Index

13

Concepts

All Affiliations

Institut Gustave Roussy
RS

About

Ray Snyder is an author at Institut Gustave Roussy specializing in breast cancer, medicine, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

31

2

Health Sciences

1

1

12

3

Obstetrics

1

1

19

4

Pathology

1

1

12

5

Cancer Epidemiology

1

1

19

Ray Snyder

×

4

Publications

1.7K

Citations

4

H-Index

YearCitations

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Michel Marty, Francesco Cognetti, D Maraninchi,

IRIS UNIMORE (University of Modena and Reggio Emilia)

2005

1.6K

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

M Marty, Francesco Cognetti, D Maraninchi,

Journal of Clinical Oncology

2005

94

Randomized comparison of adjuvant tamoxifen (Tam) versus no hormonal treatment for premenopausal women with node-positive (N+), early stage breast cancer: first results of International Breast Cancer Study Group Trial 13–93

M. Colleoni, Shari Gelber, Ray Snyder,

Journal of Clinical Oncology

2004

19

Long-term survival demonstrated with trastuzumab plus docetaxel: 24-month data from a randomised trial (M77001) in HER2-positive metastatic breast cancer

Jean-Marc Extra, F. Cognetti, D Maraninchi,

Journal of Clinical Oncology

2005

12

Page 1